Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dainippon and Sepracor Deal Emerges
Yahoo/Zacks.com
Thursday, October 15, 2009 - 10:31am
tags:
Dainippon Sumitomo, Sepracor, M&A
BioMed News Bytes: IntelGenx, Pressure BioSciences
Seeking Alpha
Thursday, October 15, 2009 - 10:29am
tags:
IntelGenx, Pressure BioSciences
Pharma Sales Managers Gripe About Lousy Training
Pharmalot
Thursday, October 15, 2009 - 10:28am
tags:
sales managers, training
Drug stocks gain; Baxter slides on earnings report
Marketwatch
Thursday, October 15, 2009 - 10:26am
tags:
drug stocks, earnings, Baxter International
Allos Closes Offering
Yahoo/Zacks.com
Thursday, October 15, 2009 - 10:25am
tags:
stock offering, Allos
Mylan gets FDA approval for generic Topamax
Forbes
Thursday, October 15, 2009 - 10:24am
tags:
FDA, generics, Mylan, Topamax, epilepsy, JNJ
On the Radar: Keep an eye on these biotech stocks
Fierce Biotech
Thursday, October 15, 2009 - 9:56am
tags:
Inspire, Human Genome Sciences, GTx, Poniard, Auxilium
Abbott Is a Winner[video]
Yahoo/TheStreet.com
Thursday, October 15, 2009 - 9:54am
tags:
Abbott Laboratories, earnings
GSK In Tune with Lilly's Chorus on Cheap-to-PoC Idea (drug development)
inVivo
Thursday, October 15, 2009 - 9:07am
tags:
drug development, GSK, Eli Lilly
Protalix says Gaucher drug met goals in trial
Yahoo/AP
Thursday, October 15, 2009 - 9:02am
tags:
Gaucher disease, Protalix BioTherapeutics, drug trials, Ulypso
Tamiflu Gives Roche A Shot In The Arm
Forbes
Thursday, October 15, 2009 - 8:59am
tags:
Roche, Tamiflu, vaccines, H1N1
Insulin drugs could lose $6.1B to biosimilars
Fierce Pharma
Wednesday, October 14, 2009 - 8:31pm
tags:
insulin, biosimilars, generics, diabetes
FDA Panel Votes 'Yes' on Acorda Drug Efficacy
TheStreet.com
Wednesday, October 14, 2009 - 8:14pm
tags:
Acorda Therapeutics, FDA, Biogen Idec, Amaya
Homes of BMS, Abbott, Novartis Execs Targeted in Late-Night Protests by Animal Rights Activists
BNET Pharma
Wednesday, October 14, 2009 - 6:07pm
tags:
activists, Bristol-Myers Squibb, Abbott Laboratories, Novartis
Analyst says Bristol-Myers may split off Mead Johnson shares, leading to gains for Mead stock
Yahoo/AP
Wednesday, October 14, 2009 - 6:05pm
tags:
Mead Johnson, Bristol-Myers Squibb
Medtronic's Passion Play: Medical device maker to test stent as alternative to Viagra
Forbes
Wednesday, October 14, 2009 - 6:04pm
tags:
erectile dysfunction, stents, Medtronic, Viagra
Little Turnaround For Big Pharma?
Forbes
Wednesday, October 14, 2009 - 6:03pm
tags:
Big Pharma
Pfizer wins U.S. antitrust approval to buy Wyeth
Reuters
Wednesday, October 14, 2009 - 1:34pm
tags:
Wyeth, Pfizer, United States, M&A
Senator probes Medicare shift to Lucentis
Fierce Pharma
Wednesday, October 14, 2009 - 10:49am
tags:
Medicare, Lucentis, Avastin, Genentech
ZIOPHARM Oncology Says Cancer Drug Promising
RTT News
Wednesday, October 14, 2009 - 10:48am
tags:
Ziopharm, cancer, palifosfamide

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.